A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)y-labeled rituximab in patients with refractory B-cell lymphoma.
Author
Publishing year
2005
Language
English
Pages
457-466
Publication/Series
Cancer Biotherapy & Radiopharmaceuticals
Volume
20
Issue
4
Links
Document type
Journal article
Publisher
Mary Ann Liebert, Inc.
Topic
- Cancer and Oncology
Status
Published
ISBN/ISSN/Other
- ISSN: 1557-8852